Aromatase Inhibitors

"Aromatase Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Compounds that inhibit AROMATASE in order to reduce production of estrogenic steroid hormones.

Descriptor ID	D047072
MeSH Number(s)	D27.505.519.389.870.300 D27.505.696.399.450.327.149 D27.505.696.399.450.855.300
Concept/Terms	Aromatase Inhibitors Aromatase Inhibitors Inhibitors, Aromatase

Below are MeSH descriptors whose meaning is more general than "Aromatase Inhibitors".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Molecular Mechanisms of Pharmacological Action [D27.505.519]
Enzyme Inhibitors [D27.505.519.389]
Steroid Synthesis Inhibitors [D27.505.519.389.870]
Aromatase Inhibitors [D27.505.519.389.870.300]
Physiological Effects of Drugs [D27.505.696]
Hormones, Hormone Substitutes, and Hormone Antagonists [D27.505.696.399]
Hormone Antagonists [D27.505.696.399.450]
Estrogen Antagonists [D27.505.696.399.450.327]
Aromatase Inhibitors [D27.505.696.399.450.327.149]
Steroid Synthesis Inhibitors [D27.505.696.399.450.855]
Aromatase Inhibitors [D27.505.696.399.450.855.300]

Below are MeSH descriptors whose meaning is related to "Aromatase Inhibitors".

Below are MeSH descriptors whose meaning is more specific than "Aromatase Inhibitors".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Aromatase Inhibitors" by people in this website by year, and whether "Aromatase Inhibitors" was a major or minor topic of these publications.

Bar chart showing 20 publications over 13 distinct years, with a maximum of 3 publications in 2011 and 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2005	0	1	1
2007	1	0	1
2008	1	0	1
2009	1	1	2
2010	2	0	2
2011	1	2	3
2012	1	1	2
2013	0	1	1
2016	0	1	1
2017	1	0	1
2018	0	1	1
2019	3	0	3
2021	1	0	1

Below are the most recent publications written about "Aromatase Inhibitors" by people in Profiles.

Mishra K, Verma SK, Ratre P, Banjare L, Jain A, Thareja S, Jain AK. In Silico Molecular Interaction Studies of Chitosan Polymer with Aromatase Inhibitor: Leads to Letrozole Nanoparticles for the Treatment of Breast Cancer. Anticancer Agents Med Chem. 2021; 21(9):1191-1199.

View in: PubMed
Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, Doubeni CA, Epling JW, Kubik M, Landefeld CS, Mangione CM, Pbert L, Silverstein M, Tseng CW, Wong JB. Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2019 09 03; 322(9):857-867.

View in: PubMed
Richards R, Keating E, Boucher JE. Targeted Therapies: Treatment Options for Patients With Metastatic Breast Cancer. Clin J Oncol Nurs. 2019 08 01; 23(4):434-438.

View in: PubMed
Bird ST, Toh S, Sahin L, Andrade SE, Gelperin K, Taylor L, Song J, Hampp C. Misclassification in Assessment of First Trimester In-utero Exposure to Drugs Used Proximally to Conception: the Example of Letrozole Utilization for Infertility Treatment. Am J Epidemiol. 2019 02 01; 188(2):418-425.

View in: PubMed
Zhang M, Park EJ, Kondratyuk TP, Pezzuto JM, Sun D. Synthesis and Structure-Activity Relationships of Tetrahydro-?-carboline Derivatives as Anticancer and Cancer-chemopreventive Agents. Anticancer Res. 2018 Aug; 38(8):4425-4433.

View in: PubMed
Prior AM, Yu X, Park EJ, Kondratyuk TP, Lin Y, Pezzuto JM, Sun D. Structure-activity relationships and docking studies of synthetic 2-arylindole derivatives determined with aromatase and quinone reductase 1. Bioorg Med Chem Lett. 2017 12 15; 27(24):5393-5399.

View in: PubMed
Fatima N, Kondratyuk TP, Park EJ, Marler LE, Jadoon M, Qazi MA, Mehboob Mirza H, Khan I, Atiq N, Chang LC, Ahmed S, Pezzuto JM. Endophytic fungi associated with Taxus fuana (West Himalayan Yew) of Pakistan: potential bio-resources for cancer chemopreventive agents. Pharm Biol. 2016 Nov; 54(11):2547-2554.

View in: PubMed
Andreani A, Leoni A, Locatelli A, Morigi R, Rambaldi M, Cervellati R, Greco E, Kondratyuk TP, Park EJ, Huang K, van Breemen RB, Pezzuto JM. Chemopreventive and antioxidant activity of 6-substituted imidazo[2,1-b]thiazoles. Eur J Med Chem. 2013 Oct; 68:412-21.

View in: PubMed
Luqman S, Meena A, Singh P, Kondratyuk TP, Marler LE, Pezzuto JM, Negi AS. Neoflavonoids and tetrahydroquinolones as possible cancer chemopreventive agents. Chem Biol Drug Des. 2012 Oct; 80(4):616-24.

View in: PubMed
Mayhoub AS, Marler L, Kondratyuk TP, Park EJ, Pezzuto JM, Cushman M. Optimization of the aromatase inhibitory activities of pyridylthiazole analogues of resveratrol. Bioorg Med Chem. 2012 Apr 01; 20(7):2427-34.

View in: PubMed

People

Explore

Similar Concepts

Top Journals